Dear Readers,
Wishing you healthy and happy days.
One of the most significant developments in epilepsy research in recent years has been the progress made in the field of genetics. In our country as well, genetic panel testing is being requested for an increasing number of patients. Particularly in the pediatric population, this practice is rapidly becoming part of routine clinical care.
But how confident are we in interpreting the results we receive from genetic laboratories? Do we feel adequately equipped to understand and evaluate these reports? In the coming years, we may all need to become more proficient in reading and interpreting genetic test results. Being prepared for this shift will undoubtedly be beneficial.
In this issue, we also present an original research article reporting that a genetic etiology was identified in 2.5% of patients followed in an epilepsy outpatient clinic. Even this figure is noteworthy and highlights the growing importance of genetic evaluation in epilepsy.
The September issue marks the beginning of a new academic season. We wish everyone a productive, successful, and enjoyable winter.
Best wishes.
S. Naz Yeni, M.D., Prof.
Editor-in-Chief
